Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Jul;112(1):25-7.
doi: 10.1172/JCI19095.

Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease

Affiliations
Comment

Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease

Paul M Sondel et al. J Clin Invest. 2003 Jul.

Abstract

Graft-versus-host disease (GVHD) represents a major cause of morbidity and mortality following conventional allogeneic hematopoietic stem cell transplantation (HSCT). A study in mice (see related article on pages 101–108) demonstrates that the selective administration of donor memory CD4+ T cells results in immune reconstitution without GVHD, a result that, if translatable to humans, has important clinical implications for HSCT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The donor graft contains both mature immune cells and primitive HSCs. T cells facilitate engraftment, protect against infection, and mediate an antileukemic effect. However, they may also initiate GVHD, a potentially fatal transplant complication. HSCs restore hematopoiesis and native immunity, the latter process requiring education of immune cells in the host thymus.
Figure 2
Figure 2
Stepwise differentiation of CD4+ T cells from naive CD4+ T cells to activated effector CD4+ T cells, and then to subsets of memory CD4+ T cells. These are divided into central memory CD4+ T cells (CD44+CD62L+CD25CCR7+) and effector memory CD4+ T cells (CD44+CD62LCD25CCR7). CD44+CD62LCD25CCR7CD4+ effector memory T cells represent a pool of terminally differentiated cells with heterogeneous immunophenotypes that express multiple patterns of chemokine receptors (i.e., CCR1, 3, or 5), tissue-specific homing receptors (i.e., CD103 and the cutaneous lymphocyte antigen [CLA]), and adhesion molecules (i.e., leukocyte function–associated antigen-1 [LFA-1] and very late antigen-4 integrin [VLA-4]), facilitating migration of these cells into different peripheral nonlymphoid tissues. The unique expression pattern and level of chemokine receptors, homing receptors, and adhesion molecules depend on the lymphoid origin (i.e., peripheral lymph nodes [PLNs], mesenteric lymph nodes [MLNs], or Peyer’s patches [PPs]) of the effector memory T cells and the duration of TCR and cytokine stimulation. These features determine the migratory and homing preferences and functional capabilities of CD44+CD62LCD25CCR7CD4+ effector memory T cells.

Comment on

References

    1. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364–1366. - PubMed
    1. Hong R, et al. Immunological restitution in lymphopenic immunological deficiency syndrome. Lancet. 1968;1:503–506. - PubMed
    1. Trigg ME, et al. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer. Treat. Rep. 1985;69:377–386. - PubMed
    1. Mackall C, Gress R. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 1997;157:61–72. - PubMed
    1. Anderson BE, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J. Clin. Invest. 2003;112:101–108. doi:10.1172/JCI200317601. - PMC - PubMed

Publication types

MeSH terms